|
Status |
Public on Jun 22, 2023 |
Title |
Methyl-CpG binding domain 2 (Mbd2) is an Epigenetic Regulator of Autism-Risk Genes and Cognition |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing Methylation profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
37443311 |
|
Submission date |
Mar 25, 2019 |
Last update date |
Sep 21, 2023 |
Contact name |
Moshe Szyf |
Organization name |
McGill University
|
Department |
Pharmacology and Therapeutics
|
Street address |
3655 William Osler Promendae
|
City |
Montreal |
State/province |
Quebec |
ZIP/Postal code |
H3G 1Y6 |
Country |
Canada |
|
|
Platforms (4)
|
GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
GPL16417 |
Illumina MiSeq (Mus musculus) |
GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
|
Samples (25)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE128612 |
Methyl-CpG binding domain 2 (Mbd2) is an Epigenetic Regulator of Autism-Risk Genes and Cognition [Bisulfite-Seq] |
GSE128703 |
Methyl-CpG binding domain 2 (Mbd2) is an Epigenetic Regulator of Autism-Risk Genes and Cognition [ChIP-seq] |
GSE128828 |
Methyl-CpG binding domain 2 (Mbd2) is an Epigenetic Regulator of Autism-Risk Genes and Cognition [RNA-seq] |
|
Relations |
BioProject |
PRJNA528976 |